- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -1.01%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 14 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 8.98% | -1.01% | -3.03% | -5.67% | -3.13% | 4.55% | 15.44% | - | - | - |
| SBI MNC FUND - REGULAR PLAN -GROWTH | 11.2% | -0.11% | -1.45% | -4.41% | 0.01% | 11.81% | 5.26% | 6.32% | 12.36% | 10.16% |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 16.01% | -0.8% | -2.95% | -6.63% | -2.66% | 13.09% | 20.5% | 15.81% | 23.96% | 13.09% |
| SBI COMMA Fund - REGULAR PLAN - Growth | 0.51% | 1.04% | -0.8% | -5.2% | -3.4% | 5.99% | 13.12% | 7.79% | 17.48% | 13.47% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -8.82% | -0.34% | -0.36% | -3.55% | -5.02% | -6.18% | 6.71% | 5.56% | 11.27% | 10.45% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | -3.13% | 0.7% | -0.87% | -3.41% | -6.19% | -0.53% | 10.47% | 13.29% | 18.01% | 13.94% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -2.59% | -6.96% | 6.8% | -4.76% | 7.57% | 2.95% | 5.81% | 3.87% | 2.74% | -2.96% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | 0.42% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.27% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.73% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.58% | |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 9.23% | |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.72% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 4.84% | |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 4.75% | |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.31% | |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.22% | |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 4.02% | |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 3.97% | |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.31% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 3.18% | |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 3.10% | |
| Global Health Limited | MEDANTA (INE474Q01031) | Healthcare Services | 2.98% | |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.92% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.82% | |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.43% | |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.97% | |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.92% | |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.59% | |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 1.59% | |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.55% | |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.50% | |
| Aster DM Quality Care Limited | ASTERDM (INE914M01019) | Healthcare Services | 1.47% | |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.32% | |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.25% | |
| Anthem Biosciences Limited | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.25% | |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.15% | |
| Thyrocare Technologies Limited | THYROCARE (INE594H01019) | Healthcare Services | 1.05% | |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.02% | |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 0.99% | |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 0.93% | |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.87% | |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.81% | |
| Metropolis Healthcare Limited | METROPOLIS (INE112L01020) | Healthcare Services | 0.74% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.71% | |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.61% | |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.60% |
Debt
| Name | Isin | Rating | Weight % | Yield |
|---|
Portfolio data is as on date 31 August, 2026
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 14 October, 2026 | 17.0471 | -1.01% |
| 13 October, 2026 | 17.2218 | -0.3% |
| 12 October, 2026 | 17.2731 | -0.01% |
| 9 October, 2026 | 17.2751 | 0.65% |
| 8 October, 2026 | 17.1643 | -2.36% |
| 7 October, 2026 | 17.5796 | -0.36% |
| 6 October, 2026 | 17.6429 | 1.11% |
| 5 October, 2026 | 17.4492 | -1.01% |
| 1 October, 2026 | 17.6281 | -0.2% |
| 30 September, 2026 | 17.6626 | -2.31% |
| 29 September, 2026 | 18.0807 | 0.17% |
| 28 September, 2026 | 18.0503 | -1.07% |
| 25 September, 2026 | 18.2447 | -0.36% |
| 24 September, 2026 | 18.3102 | -0.73% |
| 23 September, 2026 | 18.4454 | 0.83% |
| 22 September, 2026 | 18.2936 | -0.58% |
| 21 September, 2026 | 18.4005 | 1.06% |
| 18 September, 2026 | 18.2069 | 0.95% |
| 17 September, 2026 | 18.0364 | 1.45% |
| 16 September, 2026 | 17.7783 | -0.15% |
| 15 September, 2026 | 17.8053 | -1.48% |
| 11 September, 2026 | 18.0725 | -0.31% |
| 10 September, 2026 | 18.1286 | -0.46% |
| 9 September, 2026 | 18.2127 | -0.25% |
| 8 September, 2026 | 18.2591 | 0.82% |
| 7 September, 2026 | 18.1098 | 0.39% |
| 4 September, 2026 | 18.0390 | -0.62% |
| 3 September, 2026 | 18.1512 | -0.19% |
| 2 September, 2026 | 18.1854 | -0.09% |
| 1 September, 2026 | 18.2022 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 17.0471 as on 14 October, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 8.98% as on 14 October, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 4.55% as on 14 October, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 15.44% as on 14 October, 2026.What are top 10 holdings of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
Top 10 holdings of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are:- Sun Pharmaceutical Industries Limited
- Divi's Laboratories Limited
- Apollo Hospitals Enterprise Limited
- Max Healthcare Institute Limited
- Torrent Pharmaceuticals Limited
- Dr. Reddy's Laboratories Limited
- Cipla Limited
- Laurus Labs Limited
- Aurobindo Pharma Limited
- Mankind Pharma Limited
- Neuland Laboratories Limited
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.